Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 11/20 | 0.61 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.56 |
| ▸ | GBA1 | P04062 | 1/20 | 0.54 |
| ▸ | DCTPP1 | Q9H773 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1094467 | 0.88 | DGAT1 (0.54) | SCDDGAT1 | |
| SCHEMBL2429972 | 0.86 | SCD (0.60) | SCDDCTPP1LMNASMN1; SMN2MAPT | |
| SCHEMBL1096003 | 0.85 | SCD (0.67) | SCDDCTPP1LMNASMN1; SMN2KDM4E | |
| SCHEMBL1095356 | 0.85 | SCD (0.65) | SCDDCTPP1 | |
| SCHEMBL2429706 | 0.84 | SCD (0.58) | SCDDCTPP1LMNASMN1; SMN2HTT | |
| SCHEMBL14261640 | 0.84 | SCD (0.61) | SCDDCTPP1LMNASMN1; SMN2KDM4E | |
| SCHEMBL1095895 | 0.83 | SCD (0.65) | SCDDCTPP1LMNASMN1; SMN2KDM4E | |
| SCHEMBL27657512 | 0.83 | SCD (0.56) | SCDDGAT1DCTPP1LMNASMN1; SMN2 | |
| SCHEMBL1095915 | 0.83 | SCD (0.75) | SCDDCTPP1LMNASMN1; SMN2KDM4E | |
| Cyclopropane SCHEMBL2470823 | 0.82 | SCD (0.67) | SCDDCTPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1651606-B1 | PYRIDYL DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC (CA) | 2012-10-24 | — | — | EP | claimed |
| EP-1846035-B1 | COMBINATION THERAPY | XENON PHARMACEUTICALS INC (CA) | 2011-09-21 | — | — | EP | claimed |